Form 8-K - Current report:
SEC Accession No. 0001104659-21-055158
Filing Date
2021-04-27
Accepted
2021-04-27 07:30:22
Documents
2
Period of Report
2021-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114180d2_8k.htm 8-K 20455
2 EXHIBIT 10.1 tm2114180d2_ex10-1.htm EX-10.1 45398
  Complete submission text file 0001104659-21-055158.txt   67367
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21855876
SIC: 2834 Pharmaceutical Preparations